Showing results (761-770 of 806) with videos related to

Sort By:
Pageof 81
Allergy|March 14, 2026
Switching Long-Term Prophylaxis to Donidalorsen for Hereditary Angioedema: 1-Year OASISplus ResultsMarc A Riedl, Jonathan A Bernstein, Joshua S Jacobs, et al.
Science Advances|April 9, 2025
Alpha-synuclein regulates nucleolar DNA double-strand break repair in melanomaMoriah R Arnold, Gabriel M Cohn, Kezia Catharina Oxe, et al.
Allergy|November 27, 2023
A phase 2 open-label extension study of prekallikrein inhibition with donidalorsen for hereditary angioedemaRemy S Petersen, Laura Bordone, Marc A Riedl, et al.
The New England Journal of Medicine|October 24, 2024
CRISPR-Based Therapy for Hereditary AngioedemaDanny M Cohn, Padmalal Gurugama, Markus Magerl, et al.
American Journal of Preventive Medicine|August 9, 2025
Greater appeal and greater harm? Young adults' preference for menthol vs non-menthol very low nicotine cigarettes in a cross-over trialAmy M Cohn, Summer Frank-Pearce, Hoda Elmasry, et al.
Journal of the American College of Surgeons|May 30, 2009
Abdominal complications after severe burnsKatharine W Markell, Evan M Renz, Christopher E White, et al.
The Journal of Thoracic and Cardiovascular Surgery|March 1, 2020
Global perspectives on cardiothoracic, cardiovascular, and cardiac surgical trainingAlexander P Nissen, Julian A Smith, Jan Dieter Schmitto, et al.
The Journal of Prevention of Alzheimer'S Disease|November 6, 2019
Prospective Evaluation of Cognitive Health and Related Factors in Elderly at Risk for Developing Alzheimer's Dementia: A Longitudinal Cohort StudyC Udeh-Momoh, G Price, M T Ropacki, et al.
The New England Journal of Medicine|May 31, 2024
Efficacy and Safety of Donidalorsen for Hereditary AngioedemaMarc A Riedl, Raffi Tachdjian, William R Lumry, et al.
The New England Journal of Medicine|March 16, 2022
Inhibition of Prekallikrein for Hereditary AngioedemaLauré M Fijen, Marc A Riedl, Laura Bordone, et al.
Pageof 81